The global bronchoscopes market size was valued at USD 3.46 billion in 2025 and is projected to grow from USD 3.8 billion in 2026 to USD 8.02 billion by 2034 at a CAGR of 9.8% during the forecast period 2026-2034. North America dominated the bronchoscopes market with a market share of 38.4% in 2025.
Bronchoscopes are flexible or rigid medical instruments used to view the inside of the airways and lungs. They help doctors diagnose and treat respiratory conditions by inserting a thin tube through the nose or mouth to examine bronchial passages, collect samples, and perform minimally invasive procedures safely and effectively.
The bronchoscopes market demand is driven by increasing respiratory diseases, lung cancer prevalence, and growing need for minimally invasive diagnostic procedures. Advancements in imaging technology, a rising geriatric population, and higher ICU admissions are driving adoption. Hospitals and clinics are increasingly investing in bronchoscopy systems for accurate airway examination and treatment procedures.
Download a Free Sample To learn more about this report,
The bronchoscopes market is witnessing strong growth due to rising cases of lung cancer, chronic respiratory diseases, and increasing demand for minimally invasive diagnostic procedures. Hospitals are shifting toward advanced video bronchoscopes, endobronchial ultrasound (EBUS) systems, and single-use bronchoscopes to improve accuracy and reduce infection risks. In 2025, Olympus expanded its respiratory care portfolio with innovations in EBUS and peripheral bronchoscopy solutions, focusing on better lung cancer diagnosis and staging. Fujifilm also received FDA clearance for its EB-710US ultrasonic endoscope platform in 2025, supporting the trend toward advanced imaging-based bronchoscopic procedures. Artificial intelligence-based navigation and robotic bronchoscopy technologies are emerging trends, helping physicians reach difficult lung lesions with higher precision. Growing healthcare investment in Asia, especially India and China, is further accelerating adoption of modern bronchoscopy systems.
The bronchoscopes market is experiencing steady growth due to the increasing burden of respiratory diseases, rising lung cancer diagnosis rates, and growing demand for minimally invasive procedures. Healthcare providers are adopting advanced bronchoscopy technologies, including video bronchoscopes, single-use devices, and endobronchial ultrasound systems, to improve diagnostic accuracy and patient safety. The expansion of healthcare infrastructure, increasing awareness of early disease detection, and integration of artificial intelligence and robotic technologies are further supporting market growth. Emerging economies are also contributing to adoption as hospitals upgrade their respiratory care capabilities.
The bronchoscopes market faces challenges due to the high cost of advanced devices, the need for trained medical professionals, and limitations in healthcare access across developing regions. Reusable bronchoscopy systems require proper cleaning and sterilization processes, which increase operational complexity and infection control concerns. Additionally, strict regulatory requirements and competition from alternative diagnostic technologies may slow product adoption in certain healthcare settings. These factors create barriers, particularly for smaller hospitals and facilities with limited budgets.
The bronchoscopes market offers strong opportunities through the adoption of advanced technologies, including robotic bronchoscopy, AI-based navigation systems, and next-generation imaging solutions. The growing focus on early lung cancer detection is encouraging hospitals to invest in precision diagnostic tools. In 2024, several healthcare centers expanded the use of robotic-assisted bronchoscopy platforms to improve access to peripheral lung lesions that are difficult to diagnose with traditional methods. The increasing adoption of single-use bronchoscopes also creates opportunities by reducing infection risks and improving workflow efficiency. Rising healthcare investments in countries such as India, China, and Brazil are expected to support wider availability of advanced respiratory care technologies.
The bronchoscopes market faces challenges related to high equipment costs, limited availability of trained specialists, and unequal access to advanced respiratory care facilities. Robotic and AI-enabled bronchoscopy systems require significant investment, making adoption difficult for smaller hospitals and low-resource healthcare settings. Infection control remains a concern, especially for reusable bronchoscopes, as improper cleaning procedures can increase patient safety risks. In addition, regulatory approvals for new devices can be time-consuming and may delay market entry. Shortages of skilled pulmonologists in developing regions also limit the effective use of advanced bronchoscopy technologies, creating barriers to broader market expansion.
Request Customizationto receive a tailored report.
The Flexible segment is the leading segment in the bronchoscopes market, accounting for a Market Share in 2025: 81.3% due to its wide adoption in diagnostic and therapeutic procedures. Flexible bronchoscopes are preferred by healthcare professionals because they provide better maneuverability, patient comfort, and access to complex areas of the respiratory tract. Their ability to support accurate visualization, biopsy procedures, and disease evaluation has increased their use across hospitals and specialized respiratory care centers. Growing cases of lung-related disorders and increasing demand for minimally invasive diagnostic techniques are supporting the expansion of this segment. Continuous improvements in imaging quality, design flexibility, and procedural efficiency are further strengthening the importance of flexible bronchoscopes in modern healthcare.
The Disposable segment is the fastest-growing segment in the bronchoscopes market, with a CAGR: 11.24% (2026–2034), driven by increasing focus on infection prevention and improved patient safety. Disposable bronchoscopes are gaining popularity as healthcare facilities seek alternatives that reduce the risk of cross-contamination associated with reusable devices. These products eliminate the need for complex sterilization processes, helping hospitals improve workflow efficiency and maintain strict infection control standards. Rising awareness among healthcare providers, increasing surgical procedures, and growing adoption in intensive care and emergency settings are contributing to higher demand. The segment is expected to play an important role as healthcare systems continue prioritizing safer and more efficient medical equipment solutions.
The Oncology segment is the leading segment in the bronchoscopes market, holding a Market Share in 2025: 31.6% due to the increasing use of bronchoscopy procedures in lung cancer diagnosis and treatment planning. Bronchoscopes play a critical role in detecting abnormal lung tissues, collecting biopsy samples, and supporting accurate disease assessment. The rising global burden of lung cancer and the growing importance of early diagnosis are driving demand for advanced bronchoscopy technologies. Improvements in imaging systems, endobronchial ultrasound techniques, and precision-guided procedures are enhancing the effectiveness of bronchoscopic applications in oncology. Healthcare providers are increasingly adopting these solutions to improve diagnostic accuracy and support personalized treatment approaches.
The Ambulatory Surgical Centers segment is the fastest-growing segment in the bronchoscopes market, with a CAGR: 9.67% (2026–2034), supported by the increasing shift toward outpatient procedures and cost-effective healthcare delivery models. Ambulatory surgical centers are adopting advanced bronchoscopy equipment to provide efficient diagnostic and therapeutic services with shorter patient recovery times. The growing preference for minimally invasive procedures, reduced hospitalization requirements, and improved healthcare accessibility are driving demand from these facilities. As more procedures move from hospitals to specialized outpatient centers, ambulatory surgical centers are becoming an important end-user segment for bronchoscopic technologies.
Speak to an Analystto discuss market opportunities.
North America holds a regional market share of 38.4%, with a market value of USD 1.33 billion and a CAGR of 8.31%. The region’s growth is supported by increasing adoption of advanced bronchoscopy technologies, rising demand for minimally invasive respiratory procedures, and strong healthcare infrastructure. Growing focus on early diagnosis of lung diseases and the use of advanced imaging-based bronchoscopic systems are supporting market expansion across the region.
The United States is part of the North America region, where the regional market share is 38.4%, regional market value is USD 1.33 billion, and regional CAGR is 8.31%. These figures represent the overall North America market context. The country’s market growth is supported by higher adoption of advanced diagnostic technologies, increasing respiratory disease screening, and growing use of innovative bronchoscopy solutions in hospitals and specialized healthcare centers.
Canada is part of the North America region, where the regional market share is 38.4%, regional market value is USD 1.33 billion, and regional CAGR is 8.31%. These figures represent the overall North America market context. Market growth is driven by improving healthcare facilities, increasing demand for respiratory care procedures, and growing adoption of modern diagnostic equipment to support early disease detection.
Asia-Pacific holds a regional market share of 22.8%, with a market value of USD 0.79 billion and a CAGR of 10.46%. The region is experiencing strong growth due to expanding healthcare infrastructure, increasing awareness of respiratory disease diagnosis, and rising adoption of advanced medical devices. Growing healthcare investments and demand for minimally invasive procedures are supporting the adoption of bronchoscopes across developing economies.
Japan is part of the Asia-Pacific region, where the regional market share is 22.8%, regional market value is USD 0.79 billion, and regional CAGR is 10.46%. These figures represent the overall Asia-Pacific market context. Market development is supported by advanced healthcare systems, increasing demand for precision diagnostic procedures, and adoption of innovative bronchoscopy technologies in medical facilities.
China is part of the Asia-Pacific region, where the regional market share is 22.8%, regional market value is USD 0.79 billion, and regional CAGR is 10.46%. These figures represent the overall Asia-Pacific market context. Growth is supported by expanding healthcare infrastructure, increasing respiratory disease burden, and rising demand for advanced diagnostic and treatment solutions in hospitals.
Europe holds a regional market share of 27.6%, with a market value of USD 0.95 billion and a CAGR of 7.94%. The region’s market growth is supported by increasing adoption of advanced healthcare technologies, rising focus on early diagnosis, and growing demand for minimally invasive respiratory procedures. Strong healthcare systems and technological advancements are contributing to market development.
Germany is part of the Europe region, where the regional market share is 27.6%, regional market value is USD 0.95 billion, and regional CAGR is 7.94%. These figures represent the overall Europe market context. Growth is supported by advanced medical infrastructure, increasing adoption of diagnostic technologies, and growing demand for efficient respiratory care solutions.
The United Kingdom is part of the Europe region, where the regional market share is 27.6%, regional market value is USD 0.95 billion, and regional CAGR is 7.94%. These figures represent the overall Europe market context. Market growth is driven by increasing healthcare modernization, rising focus on early respiratory disease detection, and adoption of advanced bronchoscopy systems.
Latin America holds a regional market share of 6.1%, with a market value of USD 0.21 billion and a CAGR of 8.15%. The region is witnessing gradual growth due to improving healthcare access, increasing awareness of respiratory disorders, and rising adoption of diagnostic medical devices. Healthcare infrastructure development is supporting the expansion of bronchoscopy procedures across the region.
Brazil is part of the Latin America region, where the regional market share is 6.1%, regional market value is USD 0.21 billion, and regional CAGR is 8.15%. These figures represent the overall Latin America market context. Market growth is supported by increasing healthcare investments, rising demand for respiratory diagnostics, and improving availability of advanced medical technologies.
Middle East and Africa holds a regional market share of 5.1%, with a market value of USD 0.18 billion and a CAGR of 7.62%. The region’s market growth is influenced by improving healthcare infrastructure, increasing awareness of respiratory diseases, and growing adoption of advanced diagnostic equipment. Investments in healthcare facilities are supporting the gradual expansion of bronchoscopy solutions.
The UAE is part of the Middle East and Africa region, where the regional market share is 5.1%, regional market value is USD 0.18 billion, and regional CAGR is 7.62%. These figures represent the overall Middle East and Africa market context. Growth is supported by healthcare modernization, increasing adoption of advanced medical technologies, and rising demand for high-quality respiratory diagnostic procedures.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Analyst
Jay Mehta is a Research Analyst with over 4 years of experience in the Medical Devices industry. His expertise spans market sizing, technology assessment, and competitive analysis. Jay’s research supports manufacturers, investors, and healthcare providers in understanding device innovations, regulatory landscapes, and emerging market opportunities worldwide.
We are featured on:
sales@straitsresearch.com